In his previous role at Ampersand Capital Investment Advisors LLP, Rahul was the Managing Partner. He has also worked with many reputed financial institutions like Standard Chartered Securities and Citigroup Global Markets India as Head of Equity Research.
Rahul is a Bachelor of Technology in Mechanical Engineering from IIT Bombay and an alumnus of IIM Lucknow where he pursued his Master of Business Administration in Finance and Financial Management Services.
From a valuation front, valuation expansion is expected to normalize. Large cap is looking much better in terms of risk reward equation, compared to mid and small caps as large caps are lying at the lower end of 3rd quartile or 4th quartile in terms of performance.
Overall, India as an investment destination seems to be in a good shape.
Q1 FY25 result is expected to be better compared to what we saw in Q4 of FY24.
Sector performances :
Banking & financial - The Indian banking sector continues to remain in good health with an expectation of robust loan growth and healthy asset quality due to historically lower NPAs. This is expected to drive strong profitability growth trends in the coming years
Consumption - consumption is expected to get a boost led by enhanced government focus on welfare programs and rural spending. Consumer staple is likely to raise on rural support. There is likely to be more money made available, and taxations may get slightly tweaked to reduce the burden on common man.
Power, oil & gas - In a long-run, power or energy sufficiency will be the priority. Focus on renewable energy is likely to continue. In oil & gas sector, more exploration and drilling activities is expected to continue in order to meet higher demand and usage for natural gas & oil. Overall, We feel that there shouldn't be any major change in stance plot.
Infrastructure - Valuations within the sectors seem overvalued and present a decent amount of risk. We continue to be incrementally cautious for the same. It is expected a slowdown in growth of government capex while private sector CapEx expected to pick up in order to compensate for the same.
Pharmaceutical - There is no major impact of election on pharma sector. The sector remains structurally positive.